Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
Christopher J. Rhodes(University of Chicago), Martin R. Wilkins(Hammersmith Hospital), Emilia M. Swietlik(University of Cambridge), Stefan Gräf(University of Cambridge), Laura Southgate(St George's, University of London), Gerry Coghlan(The Royal Free Hospital), Inga Prokopenko(Centre for Human Genetics), David G. Kiely(Royal Hallamshire Hospital), Mark Dunning(University of Sheffield), Stephen J. Wort(Imperial College London), Nicholas W. Morrell(University of Cambridge), Richard C. Trembath(University Medical Center Groningen), Colin Church(Golden Jubilee National Hospital), Mark Toshner, Dennis Wang(Yale University), William C. Nichols(Cincinnati Children's Hospital Medical Center), James Iremonger(Immunité et Cancer), Paul A. Corris(Newcastle University), Niamh Errington(Immunité et Cancer), John Wharton(Pfizer (United Kingdom)), Lars Harbaum(Universität Hamburg), David‐Alexandre Trégouët(Inserm), Ankit A. Desai(Indiana University – Purdue University Indianapolis), A. A. Roger Thompson(University of Sheffield), Allan Lawrie(University of Sheffield), Marc Humbert(Inserm), Sokratis Kariotis(Immunité et Cancer), Jason M. Elinoff(National Institutes of Health Clinical Center), Luke Howard(Imperial College London), P. Morales Otero(Imperial College London), Joanna Pepke‐Żaba(Papworth Hospital)
Cited by 73
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k